AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,349 | +19.8% | 68,728 | -3.9% | 0.00% | – |
| Q2 2023 | $65,412 | +32.8% | 71,488 | -18.7% | 0.00% | – |
| Q1 2023 | $49,266 | +44.6% | 87,975 | +49.7% | 0.00% | – |
| Q4 2022 | $34,078 | -16.9% | 58,755 | -55.5% | 0.00% | – |
| Q3 2022 | $41,000 | -10.9% | 131,961 | +1.0% | 0.00% | – |
| Q2 2022 | $46,000 | -91.7% | 130,652 | -83.0% | 0.00% | – |
| Q1 2022 | $553,000 | -49.3% | 769,438 | +59.4% | 0.00% | – |
| Q4 2021 | $1,091,000 | -28.4% | 482,650 | -8.7% | 0.00% | – |
| Q3 2021 | $1,523,000 | +190.6% | 528,845 | +282.2% | 0.00% | – |
| Q2 2021 | $524,000 | -52.8% | 138,356 | -57.9% | 0.00% | – |
| Q1 2021 | $1,111,000 | +191.6% | 328,281 | +140.9% | 0.00% | – |
| Q4 2020 | $381,000 | -10.8% | 136,247 | -19.9% | 0.00% | – |
| Q3 2020 | $427,000 | -75.9% | 170,063 | +30.5% | 0.00% | -100.0% |
| Q2 2020 | $1,769,000 | +48.2% | 130,325 | -17.2% | 0.00% | 0.0% |
| Q1 2020 | $1,194,000 | -15.1% | 157,487 | -29.2% | 0.00% | – |
| Q4 2019 | $1,407,000 | +13.4% | 222,576 | -29.7% | 0.00% | – |
| Q3 2019 | $1,241,000 | +0.6% | 316,589 | +24.2% | 0.00% | – |
| Q2 2019 | $1,234,000 | +1.9% | 254,909 | +72.4% | 0.00% | -100.0% |
| Q1 2019 | $1,211,000 | +18.8% | 147,834 | -19.7% | 0.00% | – |
| Q4 2018 | $1,019,000 | -27.8% | 184,153 | +15.2% | 0.00% | -100.0% |
| Q3 2018 | $1,411,000 | +7.1% | 159,797 | +20.9% | 0.00% | 0.0% |
| Q2 2018 | $1,318,000 | -28.1% | 132,120 | -31.3% | 0.00% | 0.0% |
| Q1 2018 | $1,833,000 | +6.4% | 192,349 | +66.0% | 0.00% | 0.0% |
| Q4 2017 | $1,723,000 | +14.7% | 115,869 | +51.7% | 0.00% | 0.0% |
| Q3 2017 | $1,502,000 | -6.1% | 76,378 | -31.4% | 0.00% | 0.0% |
| Q2 2017 | $1,599,000 | +14.6% | 111,272 | -26.6% | 0.00% | 0.0% |
| Q1 2017 | $1,395,000 | +58.2% | 151,646 | +79.0% | 0.00% | – |
| Q4 2016 | $882,000 | -1.8% | 84,698 | -14.6% | 0.00% | -100.0% |
| Q3 2016 | $898,000 | +16.0% | 99,187 | -4.1% | 0.00% | – |
| Q2 2016 | $774,000 | +14.0% | 103,467 | +37.2% | 0.00% | – |
| Q1 2016 | $679,000 | -42.3% | 75,408 | -17.2% | 0.00% | -100.0% |
| Q4 2015 | $1,176,000 | +268.7% | 91,031 | +175.4% | 0.00% | – |
| Q3 2015 | $319,000 | -53.2% | 33,049 | -50.1% | 0.00% | – |
| Q2 2015 | $682,000 | +416.7% | 66,293 | +458.2% | 0.00% | – |
| Q1 2015 | $132,000 | -1.5% | 11,876 | +3.4% | 0.00% | – |
| Q4 2014 | $134,000 | – | 11,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |